"You may not have your eye on Alcon Inc. (NYSE: ACL), but if you wear contact lenses, suffer from dry eyes, worry about glaucoma, or even if you have hay-fever, you may have bought ACL products," notes global expert Frida Ghitis.
Here, the contributing advisor to Vivian Lewis' Global Investing, explains, "This Swiss eye drug giant has with its eyes on both the bottom line and the pipeline.
"As the world's largest eye care company, ALC has excellent management, stellar performance, promising demographics, and an intriguing ownership structure.
"Demographics bode well. Aging eyes need attention. Demand will rise for glaucoma medication, dry eye treatments, and other Alcon top sellers. As emerging markets grow their middle class, eye-care will be affordable by millions more people.
"Emerging markets can dangerous waters for U.S. investors. These markets often have little to no analyst coverage and can be highly inefficient.
"As such, this is an area where expert active management can be well worth the higher price tag. And despite charging 1.55% in annual expenses, the Templeton Emerging Markets Fund certainly falls into that category.
"Given the potential pitfalls, it's reassuring to know that this fund is overseen by Dr. Mark Mobius -- a battle-tested veteran with decades of experience dealing with these uncertain stocks.
"While most funds have no discretion when it comes to making tactical decisions, Mobius and his team have the flexibility to steer clear of troubled regions or sectors -- and overweight those that look particularly promising.
Two leading global experts have both turned bullish on France's Veolia Environnement (NYSE: VE). Vivian Lewis, in her Global Investing, notes, "Veolia is the way to play the 'water works square' on the monopoly board."
Nicholas Vardy, editor of Global Stock Investor suggests, "The smart money is betting that water may be the 'oil of the 21st century.' And Veolia is my number one way to profit from this global megatrend."
Vivan Lewis says, "We recommend buying French water and sewage conglomerate Veolia at current prices; the stock has been brought down by niggling Euro-concern about its levels of debt. The company is also being penalized for acquisitions.
"Veolia is the former Générale des Eaux, a municipal service firm. This history creates an image problem for VE which is seen as a utility.
"Our main reason for the buy, apart from price, is that this is a fast growing company with good earnings in a hot sector. In 2007, VE had revneues of euros 32.6 bn, up 14% on which its recurring net profit fost 22.5% to euros 933.2 mn. Earnings per share were euros 2.16, up 13.7%.
"Another reason for liking VE is that it is moving into China big-time, with waterworks in Tianshin and Shibai and environmental service in Juijiang. All in all, France still represents 44% of sales and the rest of Europe 36%. VE does about 10% of its business in the U.S. and the Chinese are part of the remainder.
"U.S. Global Investors (Nasdaq: GROW) has been growing its revenue and earnings at an accelerated pace over the last few years, notes Horacio Marquez, adding "And that pace is about to pick up after a recent mild respite."
The contributing editor to The Money Map explains, "We expect very strong gains in this stock to come in short order." Here, he looks at the fund management firm.
"The reason is very simple. If you couple some of the best minds in emerging-market investments and commodity investments with a comprehensive quantitative and qualitative approach, you get consistently top-performing funds with eye-popping returns.
"Last year, four of the firm's equity funds, – representing more than 80% of the money under management – were among the top performers in the overall U.S. mutual fund universe, in the one- and 10-year time periods.
"And in the fund-management business, strong, consistent fund performance drives growth in assets under management. And since growth in assets under management drives fees, it is no surprise that this company has been able to achieve operating income growth rates of between 27% to 94% over the last 10 years.
"In fact, the company should see accelerating earnings growth in the second half, as the interest rates cuts favor higher commodity prices and emerging-market investments – areas in which U.S. Global's funds excel.
Vivian Lewis, who holds GSK in her Global Investing portfolio, explains, "GlaxoSmithKline is off 22% since our purchase late in 2006, so how nice that the Oracle of Omaha sprung for it now. Why did he?
1) The stock has a a 4.5% yield, always nice. Buffett is a value player, not a growth man, especially in the current economy. Drugs are refuges in a downturn;
2) A recently defused scandal over its lead drug, diabetes treatment Avandia, whose nasty side-effects (heart trouble) surprised doctors and researchers. The heart trouble also affects competing diabetes drugs, result of too-rigorous attempts to 'normalize' blood sugar levels. There will be lawsuits but they ignore the fact that the side-effect was unanticipated;
All this recession talk has not convinced me that we are destined to have one, and I see plenty of signs that 2008 might surprise to the upside. There are plenty of problems within the US economy, and I could make a case that there is a possibility that the economy might catch cold but remedies also exist. I see the cup as half full for the stock market. This is not to say that individuals will not have to deal with hard times, they will - but the market might shine. This can happen because the market is global.
Many widely followed investment icons have a different perspective, including renowned international investor Jim Rogers in the December issue of Fortune who said, "In my view, the U.S. economy is in recession. I know the government says we're not. But as I look around, we know that automobiles are in worse than recession. The same thing is true for home-builders. Much of the financial sector is in worse than recession. So many parts of America are in worse than recession, and yet the government says we're not in a recession. I don't know what's so strong that it's offsetting these major weaknesses in the American economy. I just assume that the government is lying."
I can agree that the government is lying, but I can't agree that the economy is void of positives. There is plenty that is going strong in the economy. The defense sector is going strong as I reported on recently Defense sector rolls over S&P 500 for 8th straight year and there is every indication this will continue.
For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.
"Elbit Medical Imaging Ltd. (NASDAQ: EMITF) -- my top speculative idea for 2008 -- is about to change its name to Elbit Imaging, following shareholder approval," notes Vivian Lewis in her Global Investing Pro. Vivian was the top performer in last year's Best Stocks report, with her selection of DryShips rising nearly 400%.
"EMITF is a subsidiary of Europe Israel (M.M.S.) Ltd., which operates in the construction, operation, management and sale of shopping and entertainment centers in Israel, Central and Eastern Europe, and India.
"The company also owns hotels, primarily in major European cities, and manages and sells hotels through its Elscint Ltd. subsidiary.
"The company is also involved in investments in the research and development, production, and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, through its subsidiary InSightec Ltd.
For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.
"Although high oil prices and a weak US dollar are hurting some vacation areas, these trends are also creating enormous opportunities; indeed, Mexico is a country where the dollar still gets you a fistful of pesos and a plane ticket doesn't cost as much as an oil well," says Frida Ghitis, contributing editor for Global Investing.
"Aeropuertos del Sureste (NYSE: ASR), known as ASUR, operates nine airports," explains Ghitis. "Want to visit Mexico's Caribbean coast, luxury resorts, and nearby Mayan ruins? Unless you go by sea, chances are that you'll have to stop by one of ASUR's airports.
"One of its airports is the newly expanded Cancun facility, which saw almost ten million passengers last year. Every passenger pays airport fees, and every dollar spent on food, drinks, or gifts at the airport adds to the bottom line.
"Most of the airports are in the Southeast of the country, but the company also runs the facilities in the key tourist destinations of Oaxaca and Huatulco on the Pacific. Altogether, some 13 million passengers traveled through the company's airports last year.
For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.
"My favorite aggressive idea for 2008 is an exchange-traded fund, the New Ireland Fund (NYSE: IRL)," says Carl Delfeld, president of global investment advisory firm Chartwell Partners.
The advisor explains, "New Ireland Fund is a position in Chartwell's Country Rotation Portfolio. It has been hit hard lately due to concerns about Ireland's real estate slowdown and banking concerns.
"During the last month it has lost 30% and is trading at $22 compared to a 52-week high of $38. The top two companies in the fund are CRH PLC at 16% and Irish Allied Bank at 15%.
"The other holdings are fairly evenly distributed. Markets have overreacted leading to very attractive entry point for more speculative investors."
For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.
"The most boring part of the stock market is foreign bank non-cumulative preferred stocks," explains Vivian Lewis, in her Global Investing Pro. (Incidentally, Vivian was the #1 performer in last year's Best Stocks report.)
"But there is money to be made if you can keep your eyes open and your wits about you. For nearly 20 years, since the vehicle was invented by Barclays plc, British (and Irish) banks have issued preferred stock in denominations attractive to yield-hungry US investors, $25 at issue.
"These preferred shares have an expiration date. They normally run for ten years, after which they may be called. (They are not always called at maturity, if the issuing bank doesn't want to repay the $25 and interest rates are close to the level at which the preferred was issued.)
"They sometimes can be called at a discount from the issue price before the ten years are up, although in a period when banks are capital-hungry this is unlikely.
For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.
In referring to her conservative favorite for 2008 she explains, "While the big ships of the financial industry struggled to weather a storm of their own creation in the credit markets, a solidly built craft sailed full speed ahead undeterred by the turbulence, proudly flying the Spanish flag into new and old markets.
"Banco Santander, which trades as an ADR in the US, apparently managed to tack clear of the siren call of easy subprime money in America. Instead, following in the tradition of the conquistadors, it went in search of new riches in the old world and the new.
"With branches in Europe, Africa, and the Americas, Grupo Santander has grown to become the largest bank in Europe by market capitalization, even as its competitors see their market cap wither during difficult times.
Speaking seven languages, Vivian Lewis travels the world to uncover ideas for her Global Investing newsletter. She also monitors research from leading investment firms around the globe to add to her analysis.
To support her own bullish outlook on Israel-based Alvarion (NASDAQ: ALVR), she cites analyst Ehud Eisenstein of Oscar Gruss, who speculates that the firm could be a takeover target for Cisco (NASDAQ: CSCO).
Lewis explains, "Oscar Gruss did an update on WiMAX solutions company Alvarion, in which it reiterated its 'Buy' rating and raised its target price to $17 per share from $13. The analyst also seems to think it really can be a target for a Cisco Systems takeover bid.
"Eisenstein writes, 'Alvarion continues to lead emerging WiMAX. Our recent visit to the WiMAX World Conference in Chicago, and a comprehensive session with Alvarion management, lead us to believe that the WiMAX industry continues to make important strides, and Alvarion is well-positioned to maintain its leadership position in that space.'
"He continues, 'Management addressed their key technology differentiators, namely: greater cost-to-performance ratio, higher radio combinations, vendor agnostic approach, and the broad installation base.
"The Oscar Gruss analyst notes, 'We view Alvarion as a clear growth name. First, of the 200 WiMAX vendors who participated in WiMAX World last week, Alvarion is the only pure-play public company positioned to play the expected growth in WiMAX subscribers.'
Macquarie/First Trust invests only in infrastructure and utilities stocks. The advisor explains, "By prospectus, it is a a non-diversified portfolio of equity, debt, preferred or convertible securities, and other instruments (which may include Canadian income trusts and Australian stapled securities)."
She continues, "These holdings produce income or assets from managing, owning or operating infrastructure and utilities assets in a group of 'safe' countries. MFD also invests in infrastructure senior secured floating-rate loans."
Lewis points out the the parent company, Macquarie, has been an Australian victim of U.S. sub-prime housing loans gone sour. She notes, "The parent company may have to cover losses from two funds for Australians invested in the U.S. sub-prime market."
However, she emphasizes, "The U.S. fund that we are recommending is protected from these problems. This fund is not investing in real estate but rather in infrastructure. The sub-prime issues are bad for the management company, the Australian financial sector, and even the Austrailian dollar. But not for MFD, which is a screaming bargain."
Each day, Steven Halpern's TheStockAdvisors.com features the latest investment ideas and market commentary from the financial newsletter community.
Although global expert Vivian Lewis believe we are not yet "at the end of the correction" she continues to find selected opportunities in individual stocks, such as Israeli-based Alvarion (NASDAQ: ALVR), a leader in WiMax technology.
In her Global Investing newsletter, the advisor says, "The market's recent rise was fed by a 'shortage' of stocks; without buybacks and private equity, there will be glut."
She forecasts that as borrowing gets costlier, it will dry up investment by the corporate sector, homebuilders and consumers. And, she cautions, fixed-income vehicles will then lure investors away from the stock market.
Nevertheless, she continues to recommend select special situations, and has added Alvarion to her buy list. She explains, "WiMax started out as the commnications standard of the Israeli Army in desert campaigns, but is now widely used in countries where telephony is in its infancy, in the developing world."
Now, she says, "Alvarion's all-IP OPEN WiMAX ecosystem opens the door to complete, best-of-breed networks." She explains, "Through a new technology arrangement with ArrayComm's Advanced Multi-Antenna software, the company will be able to offer fast personal broadband network services and take this around with them."
She explains, " This will be a kind of 'always-on' IP-based service for high speed broadband. This will do email, computing, telephoning and texting, games, other consumer electronics, media, office, whatever. Another way to name it is 'DSL on the move'. We rate the stock a buy."
Each day, Steven Halpern's TheStockAdvisors.com features the latest investment ideas and market commentary from the financial newsletter community.
Last December, over 100 stocks were featured in our Top Picks for 2007 report. Now, at mid-year, we turn to the 20 advisors whose picks showed the strongest gains to get an update on their previous picks, as well as a new favorite stock for the second half of the year.
Meanwhile, the advisor now says, "DryShips is trading at a P/E of only 15, even now that the stock has gone up 300%. There is a lot of negativity about George Economou, who heads the company and now is the CFO.
"He headed a prior shipping company, which filed for bankruptcy after it could not pay back loans to British banks a decade ago. This was in the DryShips prospectus of course, and was also the subject of a report written by Kate Welling (former Barron's reporter) for a group shorting DRYS, including the Weeden brokerage firm.
"As a result, all this maybe makes DRYS cheaper than in would be otherwise. When I recommended DRYS in Global Investing in December 2005, I wanted it for its yield of 7.8%. That went up to 8.4% a year ago when the shorts were out in force, and the stock fell from $12.75 (our buy level) to $9.50.
"So the recovery is nice, but there is still an 'odor' around, which is why the resignation of the second CFO in a year causes some upset. I'm not giving up on this stock and indeed, perhaps would want to buy on weakness -- although as a holder, I am not sure I want to see weakness."